108 related articles for article (PubMed ID: 8105301)
21. [Treatment of hepatic veno-occlusive disease after bone marrow transplantation with recombinant human tissue plasminogen activator (rh-tPA)].
Yoshimi A; Kato K; Maeda N; Matsuyama T; Kojima S
Rinsho Ketsueki; 2000 Feb; 41(2):103-8. PubMed ID: 10723238
[TBL] [Abstract][Full Text] [Related]
22. Alteplase for hepatic veno-occlusive disease after bone-marrow transplantation.
Rosti G; Bandini G; Belardinelli A; Calori E; Tura S; Gherlinzoni F; Miggiano C
Lancet; 1992 Jun; 339(8807):1481-2. PubMed ID: 1351153
[No Abstract] [Full Text] [Related]
23. A review of tissue plasminogen activator in the treatment of veno-occlusive liver disease after bone marrow transplantation.
Terra SG; Spitzer TR; Tsunoda SM
Pharmacotherapy; 1997; 17(5):929-37. PubMed ID: 9324182
[TBL] [Abstract][Full Text] [Related]
24. Alteplase for hepatic veno-occlusive disease complicating bone-marrow transplantation.
Laporte JP; Lesage S; Tilleul P; Najman A; Gorin NC
Lancet; 1992 Apr; 339(8800):1057. PubMed ID: 1349081
[No Abstract] [Full Text] [Related]
25. Von Willebrand factor, angiotensin converting enzyme and endothelial cell damage in veno-occlusive disease and bone marrow transplantation.
Blann A; Collins P
Thromb Res; 1992 Jun; 66(5):617-8. PubMed ID: 1326136
[No Abstract] [Full Text] [Related]
26. Alteplase for hepatic veno-occlusive disease after bone marrow transplantation.
Ringdén O; Wennberg L; Ericzon BG; Kallman R; Aström M; Duraj F; Söderdahl G; Tydén G; Groth CG
Lancet; 1992 Aug; 340(8818):546-7. PubMed ID: 1354293
[No Abstract] [Full Text] [Related]
27. Fatal hemorrhage after recombinant tissue plasminogen activator therapy for hepatic veno-occlusive disease complicating autologous BMT.
Otheo de Tejada E; Maldonado MS; Camarero C; Muñoz A
Bone Marrow Transplant; 1994 Jul; 14(1):176-7. PubMed ID: 7951113
[No Abstract] [Full Text] [Related]
28. Veno-occlusive disease of the liver after marrow transplantation: histological correlates of clinical signs and symptoms.
Shulman HM; Fisher LB; Schoch HG; Henne KW; McDonald GB
Hepatology; 1994 May; 19(5):1171-81. PubMed ID: 8175139
[TBL] [Abstract][Full Text] [Related]
29. [Veno-occlusive disease of the liver].
Rybicka M; Krysiak R; Okopień B
Wiad Lek; 2009; 62(1):42-51. PubMed ID: 19817257
[TBL] [Abstract][Full Text] [Related]
30. Recombinant human tissue plasminogen activator for the treatment of severe hepatic veno-occlusive disease in pediatric bone marrow transplant patients.
Leahey AM; Bunin NJ
Bone Marrow Transplant; 1996 Jun; 17(6):1101-4. PubMed ID: 8807121
[TBL] [Abstract][Full Text] [Related]
31. Nonbacterial thrombotic endocarditis clinically mimicking veno-occlusive disease of the liver complicating autologous bone marrow transplantation.
Vukelja SJ; Baker WJ; Jeffreys P; Reeb BA; Pick T
Am J Clin Oncol; 1992 Dec; 15(6):500-2. PubMed ID: 1449113
[TBL] [Abstract][Full Text] [Related]
32. Homocysteine and prothrombin fragment 1+2 levels in patients with veno-occlusive disease after stem cell transplantation.
Gerecitano J; Mathias C; Mick R; Duffy KM; Luger S; Stadtmauer EA; Schuster SJ; Tsai D; Nasta S; Berlin J; Phillips DK; High KA; Porter DL
J Hematother Stem Cell Res; 2003 Apr; 12(2):215-23. PubMed ID: 12804180
[TBL] [Abstract][Full Text] [Related]
33. High plasma levels of tumor necrosis factor-alpha may be predictive of veno-occlusive disease in bone marrow transplantation.
Gugliotta L; Catani L; Vianelli N; Gherlinzoni F; Miggiano MC; Bandini G; Tura S
Blood; 1994 Apr; 83(8):2385-6. PubMed ID: 8161809
[No Abstract] [Full Text] [Related]
34. Successful treatment of veno-occlusive disease with recombinant tissue plasminogen activator in a patient requiring peritoneal dialysis.
Simpson DR; Browett PJ; Doak PB; Palmer SJ
Bone Marrow Transplant; 1994 Oct; 14(4):635-6. PubMed ID: 7858540
[TBL] [Abstract][Full Text] [Related]
35. Recombinant tissue plasminogen activator for treatment of hepatic veno-occlusive disease following bone marrow transplantation in children: effectiveness and a scoring system for initiating treatment.
Bajwa RP; Cant AJ; Abinun M; Flood TJ; Hodges S; Hale JP; Skinner R
Bone Marrow Transplant; 2003 Apr; 31(7):591-7. PubMed ID: 12692627
[TBL] [Abstract][Full Text] [Related]
36. Veno-occlusive disease of the liver complicating ABMT successfully treated with recombinant tissue plasminogen activator (rt-PA).
Baglin TP; Harper P; Marcus RE
Bone Marrow Transplant; 1990 Jun; 5(6):439-41. PubMed ID: 2369685
[TBL] [Abstract][Full Text] [Related]
37. Defibrotide as salvage therapy for refractory veno-occlusive disease of the liver complicating allogeneic bone marrow transplantation.
Abecasis MM; Conceição Silva JP; Ferreira I; Guimarães A; Machado A
Bone Marrow Transplant; 1999 Apr; 23(8):843-6. PubMed ID: 10231151
[TBL] [Abstract][Full Text] [Related]
38. New insights into sinusoidal obstruction syndrome.
Piccin A; Sartori MT; Bisogno G; Van Schilfgaarde M; Saggiorato G; Pierro AMD; Corvetta D; Marcheselli L; Mega A; Gastl G; Cesaro S
Intern Med J; 2017 Oct; 47(10):1173-1183. PubMed ID: 28707749
[TBL] [Abstract][Full Text] [Related]
39. Hypercoagulability in patients undergoing autologous or allogeneic BMT for hematological malignancies.
Catani L; Gugliotta L; Mattioli Belmonte M; Vianelli N; Gherlinzoni F; Miggiano MC; Belardinelli AR; Rosti G; Calori E; Bandini G
Bone Marrow Transplant; 1993 Sep; 12(3):253-9. PubMed ID: 8241985
[TBL] [Abstract][Full Text] [Related]
40. Hepatic veno-occlusive disease--liver toxicity syndrome after bone marrow transplantation.
Shulman HM; Hinterberger W
Bone Marrow Transplant; 1992 Sep; 10(3):197-214. PubMed ID: 1422475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
